Copyright
©The Author(s) 2023.
Figure 1 Contraindications of monoclonal antibody therapy.
COVID-19: Coronavirus disease 2019.
Figure 2 High-risk groups indicated for treatment with monoclonal antibodies.
CVD: Cardiovascular disease; HTN: Hypertension; COPD: Chronic obstructive pulmonary disease; BMI: Body mass index; CKD: Chronic kidney disease.
- Citation: Bajpai J, Kant S, Verma AK, Pradhan A. Monoclonal antibody for COVID-19: Unveiling the recipe of a new cocktail. World J Respirol 2023; 12(1): 1-9
- URL: https://www.wjgnet.com/2218-6255/full/v12/i1/1.htm
- DOI: https://dx.doi.org/10.5320/wjr.v12.i1.1